Skip to main content
Fig. 2 | Breast Cancer Research

Fig. 2

From: Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial

Fig. 2

Kaplan-Meier curves of time to treatment failure (TTF) in the overall population (a). Box plots and comparison of TTF of patients who received only 1 or ≥ 2 lines of endocrine therapy prior to trial enrolment (b). Box plots and comparison of TTF of patients who received chemotherapy or endocrine therapy as next-line treatment (c). Abbreviations: P = palbociclib. ET = endocrine therapy. TTF = time to treatment failure. CT = chemotherapy

Back to article page